Pomalidomide-PEG6-butyl iodide
1835705-74-2
98%
5kg/bag
Yes
2025-10-10
Nootropics,Sarms,Peptides,API,Intermediates
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Pomalidomide-PEG6-butyl iodide
Other Name:Pomalidomide-PEG6-butyl iodide;Pomalidomide-2-2-2-2-2-2-6-I;Acetamide, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-2-[(21-iodo-3,6,9,12,15-pentaoxaheneicos-1-yl)oxy]-;N-(2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-24-iodo-3,6,9,12,15,18-hexaoxatetracosanamide, Crosslinker?E3 Ligase ligand conjugate, Pomalidomide-2-2-2-2-2-2-6-I, Protein degrader building block for PROTAC? research, Template for synthesis of targeted protein degrader;Pomalidomide-PEG?-butyl iodide;N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]-24-iodo-3,6,9,12,15,18-hexaoxatetracosanamide;Pomalidomide-PEG6-butyl iodide
CAS No.:1835705-74-2
Molecular Formula:C31H44IN3O11
InChIKeys:NPWUUZRWHPEICJ-UHFFFAOYSA-N
Molecular Weight:761.6
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.448±0.06 g/cm3(Predicted)
Boiling Point:853.5±65.0 °C(Predicted)
PKA:10.68±0.40(Predicted)
Critical Temperature & Pressure:2-8°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Nootropics,Sarms,Peptides,API,Intermediates
-
Location:
Kemp House, 160 City Road London, EC1V 2NX
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Biopol PHBV powder (80181-31-3)
Pharmaceutical Grade / 98%
-
-
-
-
9-Me-Bc - 2521-07-5 - 98%
Pharmaceutical Grade / 98%
-
-
-
-
DBCO-PEG4-NH-Boc
Pharmaceutical Grade / 98%
-
-
-
-
TAK-653 98% Powder
Pharmaceutical Grade / 98%
-
-
-
-
ACP-105
Pharmaceutical Grade / 98%
-
-
-
-
Epitalon Vials/Powder - 307297-39-8 - 98%
Pharmaceutical Grade / 98%
-